Cutaneous Oncology News

Study findings that platelet-rich plasma in combination with 5% minoxidil solution showed efficacy in hair regrowth for patients with androgenetic alopecia compared with the combination with oral finasteride, was among the top read articles in June on Healio.com/Dermatology.

Pathologists had lower levels of accuracy and reproducibility in diagnosing moderate dysplastic nevus, melanoma in situ and early stage invasive melanoma, compared with benign nevi and high stage invasive melanoma, according to recently published study results in BMJ.

The American Academy of Dermatology Association has issued a statement from its president opposing the repeal of the tax on indoor tanning services that is a provision in the Senate’s Better Care Reconciliation Act.

Patients with melanoma continued to experience tumor response to nivolumab monotherapy when treated beyond progression, according to a pooled analysis of data from the CheckMate 066 and CheckMate 067 studies.

The FDA’s approval of Baxdela for treating acute bacterial skin and skin structure infections was among the top read articles of the past week on Healio.com/Dermatology.

Novartis reported net sales of $11.5 billion in the first quarter compared with $11.6 billion in the same quarter of 2016, according to a press release.

Findings that tildrakizumab showed efficacy as treatment for patients with moderate-to-severe chronic plaque psoriasis compared with placebo or Enbrel was among the top read articles of the past week on Healio.com/Dermatology.

While certain histopathologic features of difficult-to-diagnose lesions significantly influenced the final diagnosis of melanoma, some features varied in accuracy and predictability, according to recently published study results in the Journal of the American Academy of Dermatology.

Case report study results that Keytruda therapy was associated with eruptive keratoacanthomas in three patients with metastatic squamous cell carcinoma or metastatic melanoma was among recent developments reported on Healio.com/Dermatology.

La Roche-Posay highlighted the most recent developments of My UV Patch at VivaTech in Paris, which were made to include children and adolescents.